关于RAB13在肿瘤发生发展中作用的研究进展
Research Progress on the Role of RAB13 in Tumorigenesis and Tumor Development
DOI: 10.12677/wjcr.2026.163020, PDF,    科研立项经费支持
作者: 宋文涛:上海交通大学医学院附属第八人民医院普外科,上海;黄修燕*:上海交通大学医学院附属第六人民医院普外科,上海
关键词: RAB13肿瘤发生肿瘤转移肿瘤微环境RAB13 Tumorigenesis Tumor Metastasis Tumor Microenvironment
摘要: RAB13属于RAS相关小GTP酶(RAB)家族,在细胞内主要参与囊泡运输和膜蛋白的循环回收。由于这些基础功能,它在维持细胞极性、保持紧密连接结构完整以及引导定向迁移等过程中都不可或缺。近年来,越来越多的研究注意到RAB13在多种恶性肿瘤中存在异常表达,并且这种异常并非孤立现象——该蛋白能够通过多条途径介入肿瘤的恶性进程,包括调控肿瘤干细胞微环境、介导上皮–间质转化、影响细胞外囊泡介导的通讯,以及诱导治疗抵抗等。基于上述背景,文章首先介绍RAB13的分子结构特征和基本生物学功能,其次系统总结其在恶性肿瘤中的表达异常模式、关键作用机制及预后价值,最后对靶向RAB13的小分子抑制剂筛选和老药新用等治疗探索进行梳理。希望能为深入理解RAB13在肿瘤进展中的复杂角色,以及后续诊疗方法的开发提供一定的理论参考。
Abstract: RAB13 belongs to the RAS-related small GTPase (RAB) family and is mainly involved in vesicle transport and membrane protein recycling in cells. Due to these basic functions, it is indispensable in maintaining cell polarity, maintaining the integrity of the tight junction structure, and guiding directional migration. In recent years, more and more studies have noted that RAB13 is abnormally expressed in a variety of malignant tumors, and this abnormality is not an isolated phenomenon—the protein can intervene in the malignant progression of tumors through multiple pathways, including regulating the tumor stem cell microenvironment, mediating epithelial-mesenchymal transition, affecting extracellular vesicle-mediated communication, and inducing treatment resistance. Based on the above background, this paper first introduces the molecular structure characteristics and basic biological functions of RAB13, then systematically summarizes its abnormal expression pattern, key mechanism, and prognostic value in malignant tumors, and finally sorts out the treatment exploration of small molecule inhibitor screening and new use of old drugs targeting RAB13. It is hoped to provide a theoretical reference for further understanding the complex role of RAB13 in tumor progression and the development of subsequent diagnosis and treatment methods.
文章引用:宋文涛, 黄修燕. 关于RAB13在肿瘤发生发展中作用的研究进展[J]. 世界肿瘤研究, 2026, 16(3): 188-194. https://doi.org/10.12677/wjcr.2026.163020

参考文献

[1] Han, L., Meng, Y. and Jianguo, Z. (2024) Research Progress of PD 1/PD L1 Inhibitors in the Treatment of Urological Tumors. Current Cancer Drug Targets, 24, 1104-1115. [Google Scholar] [CrossRef] [PubMed]
[2] Sparrer, D., Blazquez, R., Keil, F., Einhell, S., Lüke, F., Uderhardt, S., et al. (2025) Primary and Secondary Metastatic Dissemination: Multiple Routes to Cancer-Related Death. Molecular Cancer, 24, Article No. 203. [Google Scholar] [CrossRef] [PubMed]
[3] Stenmark, H. (2009) Rab GTPases as Coordinators of Vesicle Traffic. Nature Reviews Molecular Cell Biology, 10, 513-525. [Google Scholar] [CrossRef] [PubMed]
[4] Ji, Y., Li, R., Tang, G., Wang, W., Chen, C. and Yang, Q. (2025) The Interrelated Roles of RAB Family Proteins in the Advancement of Neoplastic Growth. Frontiers in Oncology, 15, Article ID: 1513360. [Google Scholar] [CrossRef] [PubMed]
[5] Hutagalung, A.H. and Novick, P.J. (2011) Role of Rab GTPases in Membrane Traffic and Cell Physiology. Physiological Reviews, 91, 119-149. [Google Scholar] [CrossRef] [PubMed]
[6] Nokes, R.L., Fields, I.C., Collins, R.N. and Fölsch, H. (2008) RAB13 Regulates Membrane Trafficking between TGN and Recycling Endosomes in Polarized Epithelial Cells. The Journal of Cell Biology, 182, 845-853. [Google Scholar] [CrossRef] [PubMed]
[7] Lee, H., Kim, B., Park, J., Park, S., Yoo, G., Yum, S., et al. (2025) Cancer Stem Cells: Landscape, Challenges and Emerging Therapeutic Innovations. Signal Transduction and Targeted Therapy, 10, Article No. 248. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, H., Xu, H., Chen, W., Cheng, M., Zou, L., Yang, Q., et al. (2022) Rab13 Sustains Breast Cancer Stem Cells by Supporting Tumor-Stroma Cross-Talk. Cancer Research, 82, 2124-2140. [Google Scholar] [CrossRef] [PubMed]
[9] Hinger, S.A., Abner, J.J., Franklin, J.L., Jeppesen, D.K., Coffey, R.J. and Patton, J.G. (2020) Rab13 Regulates SEV Secretion in Mutant KRAS Colorectal Cancer Cells. Scientific Reports, 10, Article No. 15804. [Google Scholar] [CrossRef] [PubMed]
[10] Huang, X., Zhang, J., Li, F., Li, T., Shi, X., Huang, J., et al. (2023) Exosomal Proteomics Identifies Rab13 as a Potential Regulator of Metastasis for HCC. Hepatology Communications, 7, e0006-e0006. [Google Scholar] [CrossRef] [PubMed]
[11] Chen, P., Chen, G., Wang, C. and Mao, C. (2019) Rab13 as a Novel Prognosis Marker Promotes Proliferation and Chemotherapeutic Resistance in Gastric Cancer. Biochemical and Biophysical Research Communications, 519, 113-120. [Google Scholar] [CrossRef] [PubMed]
[12] Wu, C., Agrawal, S., Vasanji, A., Drazba, J., Sarkaria, S., Xie, J., et al. (2011) Rab13-Dependent Trafficking of Rhoa Is Required for Directional Migration and Angiogenesis. Journal of Biological Chemistry, 286, 23511-23520. [Google Scholar] [CrossRef] [PubMed]
[13] Guo, J., Han, X., Li, J., Li, Z., Yi, J., Gao, Y., et al. (2023) Single-Cell Transcriptomics in Ovarian Cancer Identify a Metastasis-Associated Cell Cluster Overexpressed Rab13. Journal of Translational Medicine, 21, Article No. 254. [Google Scholar] [CrossRef] [PubMed]
[14] Ioannou, M.S., Bell, E.S., Girard, M., Chaineau, M., Hamlin, J.N.R., Daubaras, M., et al. (2015) DENND2B Activates Rab13 at the Leading Edge of Migrating Cells and Promotes Metastatic Behavior. Journal of Cell Biology, 208, 629-648. [Google Scholar] [CrossRef] [PubMed]
[15] Yang, S., Chen, M. and Lin, C. (2019) A Novel LncRNA MYOSLID/miR-1286/RAB13 Axis Plays a Critical Role in Osteosarcoma Progression. Cancer Management and Research, 11, 10345-10351. [Google Scholar] [CrossRef] [PubMed]
[16] Sun, J., Sun, Z., Gareev, I., Yan, T., Chen, X., Ahmad, A., et al. (2021) Exosomal miR-2276-5p in Plasma Is a Potential Diagnostic and Prognostic Biomarker in Glioma. Frontiers in Cell and Developmental Biology, 9, Article ID: 671202. [Google Scholar] [CrossRef] [PubMed]
[17] Mo, W., Zhang, J., Li, X., Meng, D., Gao, Y., Yang, S., et al. (2013) Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling through Critical Pathways to Regulate Cell Viability in Prostate Cancer. PLOS ONE, 8, e56592. [Google Scholar] [CrossRef] [PubMed]
[18] Jiang, C., Liu, Z., Yuan, J., Wu, Z., Kong, L., Yang, J., et al. (2023) Construction of Two Independent RAB Family-Based Scoring Systems Based on Machine Learning Algorithms and Definition of RAB13 as a Novel Therapeutic Target for Hepatocellular Carcinoma. International Journal of Molecular Sciences, 24, Article 4335. [Google Scholar] [CrossRef] [PubMed]
[19] 宋静, 苏磊, 范泽彦, 等. RNA解旋酶DDX5在癌症中的研究进展[J]. 世界肿瘤研究, 2025, 15(3): 124-131.
[20] Li, Z., Kim, W., Utturkar, S., Yan, B., Lanman, N.A., Elzey, B.D., et al. (2024) DDX5 Deficiency Drives Non-Canonical NF-κB Activation and NRF2 Expression, Influencing Sorafenib Response and Hepatocellular Carcinoma Progression. Cell Death & Disease, 15, Article No. 583. [Google Scholar] [CrossRef] [PubMed]
[21] Shimada, K., Uzawa, K., Kato, M., Endo, Y., Shiiba, M., Bukawa, H., et al. (2005) Aberrant Expression of Rab1A in Human Tongue Cancer. British Journal of Cancer, 92, 1915-1921. [Google Scholar] [CrossRef] [PubMed]
[22] Thomas, J.D., Zhang, Y., Wei, Y., Cho, J., Morris, L.E., Wang, H., et al. (2014) Rab1A Is an mTORC1 Activator and a Colorectal Oncogene. Cancer Cell, 26, 754-769. [Google Scholar] [CrossRef] [PubMed]
[23] Xu, B.H., Li, X.X., Yang, Y., Zhang, M., Rao, H., Wang, H., et al. (2015) Aberrant Amino Acid Signaling Promotes Growth and Metastasis of Hepatocellular Carcinomas through Rab1A-Dependent Activation of mTORC1 by Rab1A. Oncotarget, 6, 20813-20828. [Google Scholar] [CrossRef] [PubMed]
[24] Zhang, X.D., Liu, Z.Y., Luo, K.Z., Wang, X., Wang, M., Huang, S., et al. (2023) Clinical Implications of Rab13 Expression in Pan-Cancer Based on Multi-Databases Integrative Analysis. Scientific Reports, 13, Article No. 16859. [Google Scholar] [CrossRef] [PubMed]
[25] Lv, F., Li, X., Wang, Z., Wang, X. and Liu, J. (2024) Identification and Validation of Rab GTPases Rab13 as Biomarkers for Peritoneal Metastasis and Immune Cell Infiltration in Colorectal Cancer Patients. Frontiers in Immunology, 15, Article ID: 1403008. [Google Scholar] [CrossRef] [PubMed]
[26] Su, W., Liao, M., Tan, H., Chen, Y., Zhao, R., Jin, W., et al. (2021) Identification of Autophagic Target Rab13 with Small‐Molecule Inhibitor in Low‐Grade Glioma via Integrated Multi‐Omics Approaches Coupled with Virtual Screening of Traditional Chinese Medicine Databases. Cell Proliferation, 54, e13135. [Google Scholar] [CrossRef] [PubMed]